Lithium and preventing chemotherapy-induced peripheral neuropathy in breast cancer patients: a placebo-controlled randomized clinical trial

Lithium and preventing chemotherapy-induced peripheral neuropathy in breast cancer patients: a placebo-controlled randomized clinical trial

Abstract Background Chemotherapy-induced peripheral neuropathy (CIPN) is a common adverse effect of some chemotherapy regimens. Lithium has been suggested for CIPN in some animal studies. We aimed to study lithium’s preventive effect on CIPN in breast cancer patients treated with taxanes and platinu...

Full description

Bibliographic Details
Main Authors: S. Najafi, Z. Heidarali, M. Rajabi, Z. Omidi, F. Zayeri, M. Salehi, S. Haghighat
Format: Article
Language:English
Published: BMC 2021-11-01
Series:Trials
Subjects:
Chemotherapy
Prevention
Peripheral neuropathy
Lithium
Breast cancer
Online Access:https://doi.org/10.1186/s13063-021-05800-w

Internet

https://doi.org/10.1186/s13063-021-05800-w

Similar Items